101 related articles for article (PubMed ID: 7156513)
1. Measurement of the cell loss from two spontaneous canine tumours.
Holmes JM
Res Vet Sci; 1982 Nov; 33(3):375-7. PubMed ID: 7156513
[TBL] [Abstract][Full Text] [Related]
2. A 125IUdR technique for measuring the cell loss from subcutaneously growing canine transmissible venereal tumours.
Holmes JM
Res Vet Sci; 1981 Nov; 31(3):306-11. PubMed ID: 7342225
[TBL] [Abstract][Full Text] [Related]
3. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice.
Holmes JM
Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-yes oncogene product in various animal tissues and spontaneous canine tumours.
Rungsipipat A; Tateyama S; Yamaguchi R; Uchida K; Miyoshi N
Res Vet Sci; 1999 Jun; 66(3):205-10. PubMed ID: 10333460
[TBL] [Abstract][Full Text] [Related]
5. A survey on neoplasia in domestic species over a 40-year period from 1935 to 1974 in the Republic of South Africa. VI. Tumours occurring in dogs.
Bastianello SS
Onderstepoort J Vet Res; 1983 Sep; 50(3):199-220. PubMed ID: 6646663
[TBL] [Abstract][Full Text] [Related]
6. Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours.
Wergin MC; Kaser-Hotz B
In Vivo; 2004; 18(1):15-9. PubMed ID: 15011746
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures.
Von Euler H; Khoshnoud R; He Q; Khoshnoud A; Fornander T; Rutqvist LE; Skog S
Int J Mol Med; 2005 Dec; 16(6):979-85. PubMed ID: 16273275
[TBL] [Abstract][Full Text] [Related]
8. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
9. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
Taylor F; Gear R; Hoather T; Dobson J
J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
[TBL] [Abstract][Full Text] [Related]
10. Cell production rates in human tissues and tumours and their significance. Part II: clinical data.
Rew DA; Wilson GD
Eur J Surg Oncol; 2000 Jun; 26(4):405-17. PubMed ID: 10873364
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
12. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
13. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
14. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
15. Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations.
Rew DA; Wilson GD
Eur J Surg Oncol; 2000 Apr; 26(3):227-38. PubMed ID: 10753534
[TBL] [Abstract][Full Text] [Related]
16. Interrelation of directly measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumours.
Rohrer Bley C; Wergin M; Roos M; Grenacher B; Kaser-Hotz B
Eur J Cancer; 2007 Mar; 43(5):963-7. PubMed ID: 17254768
[TBL] [Abstract][Full Text] [Related]
17. [Determination of the potential doubling time of tumors using bromodeoxyuridine and flow cytometry].
Schwyn U; Kaser-Hotz B; Hauser B; Fodor G; Ruckstuhl H; Crompton NE
Schweiz Arch Tierheilkd; 1997; 139(10):441-8. PubMed ID: 9441381
[TBL] [Abstract][Full Text] [Related]
18. The role of hypoxia in canine cancer.
Snyder SA; Dewhirst MW; Hauck ML
Vet Comp Oncol; 2008 Dec; 6(4):213-23. PubMed ID: 19178681
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
20. Canine mammary tumour cell lines established in vitro.
Hellmén E
J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
